| Pharmaceutical active ingredients: |
| Diatrizoate MeglumineIodipamide Meglumine |
| Available forms, composition and doses of Sinografin: |
| Solution; Intrauterine; Diatrizoate Meglumine 52.7%; Iodipamide Meglumine 26.8% |
| Sinografin medical category: |
| Human:Roentgenography |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| V08AA - Watersoluble, nephrotropic, high osmolar X-Ray contrast media |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Bristol-Myers SquibbBracco |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Urografina | Diatrizoate Meglumine; Diatrizoate Sodium | Bayer Schering Pharma |
| Urografine | Diatrizoate Meglumine; Diatrizoate Sodium | Bayer Schering Pharma |
| Urographin | Diatrizoate Meglumine; Diatrizoate Sodium | Bayer Schering Pharma; Berlimed; Sotex |
| Urovison | Diatrizoate Meglumine; Diatrizoate Sodium | Bayer Schering Pharma; German Remedies; Zydus Cadila |
| Urovisona | Diatrizoate Meglumine; Diatrizoate Sodium | Bayer Schering Pharma |
| Hypaque | Diatrizoate Sodium | Amersham; Abbott; GE Healthcare; Intrapharm Laboratories; Nycomed; Sanofi-Aventis |
| MD-50 | Diatrizoate Sodium | Mallinckrodt |
| Urovist Sodium | Diatrizoate Sodium | Bayer Schering Pharma; Berlex Laboratories |
| Urovist Sodium 300 | Diatrizoate Sodium | Bayer Schering Pharma; Berlex Laboratories |
| Radioselectan Urinaire | Diatrizoate Sodium; Iodine (Diatrizoate Meglumine) | Bayer Schering Pharma |